18:46 IST
NSE
Management Change
India Glycols Management Change
India Glycols Ltd announced that four senior management personnel ceased their roles following the effective date of a previously disclosed Scheme of Arrangement.
India Glycols Ltd
- Share price
- ₹382.70
- Market cap
- ₹2,565 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 8.1×Sector 36.8×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 4Merger & Restructuring 3Annual General Meeting 3Other Announcement 2Earnings Call 2Price Movement Clarification 1Financial Results 1Business Update 1Board Meeting Outcome 1Board Meeting Date 1
Time
4 announcements with these filters
19:26 IST
BSE
Management Change
India Glycols Management Change
India Glycols' subsidiary, Ennature Bio Pharma, announced the appointment of new Directors and a Managing Director. These appointments are part of ongoing corporate updates.
17:07 IST
BSE
Management Change
India Glycols Management Change
India Glycols Ltd re-designated Ms. Pragya Bhartia Barwale from Whole Time Director and KMP to Non-Executive Non-Independent Director, effective August 12, 2026.
16:59 IST
BSE
Management Change
India Glycols Management Change
Shri Akshay Bansal, a Senior Managerial Personnel (SMP) at India Glycols Limited, has been transferred to its subsidiary, Ennature Bio Pharma Limited, as an Executive Director.